Some interesting observations on the slides and am especially interested in the identification of building in patient opinions from an early stage. This is an aspect that I think is often strangely overlooked but worked with can produce better outcomes for patients and those that treat them.
Thank you for sharing and for the comment Christine. IMHO building in patients (or doctors) opinions from an early stage is going to be increasingly important as pharma looks to deliver content and assets that are both effective and have impact. Working with stakeholders to co-create these will help ensure they deliver value to their target audiences. Co-creation looks like being one of this year’s buzzwords and trends.
Some interesting observations on the slides and am especially interested in the identification of building in patient opinions from an early stage. This is an aspect that I think is often strangely overlooked but worked with can produce better outcomes for patients and those that treat them.
Thank you for sharing and for the comment Christine. IMHO building in patients (or doctors) opinions from an early stage is going to be increasingly important as pharma looks to deliver content and assets that are both effective and have impact. Working with stakeholders to co-create these will help ensure they deliver value to their target audiences. Co-creation looks like being one of this year’s buzzwords and trends.
It doesn’t make sense anymore to design solutions without patient input from the outset and right the way through.